Genetic central nervous system and retinal vascular disease

Genetic central nervous system (CNS) and retinal vascular disease is a group classification used by Orphanet (ORPHA:183503) to categorize rare inherited conditions that primarily affect the blood vessels of the brain and the retina of the eye. This grouping encompasses several distinct genetic disorders in which abnormal development or function of small and medium-sized blood vessels leads to progressive neurological and ophthalmological complications. Conditions within this category share the common feature of vascular pathology affecting both the central nervous system and the retinal vasculature, though the specific genetic causes, inheritance patterns, and clinical presentations vary among the individual diseases included. Key clinical features across disorders in this group may include retinal vascular abnormalities (such as retinal telangiectasia, exudative retinopathy, or retinal ischemia), cerebral small vessel disease, stroke or stroke-like episodes, white matter lesions, cognitive decline, visual impairment, and in some cases leukoencephalopathy. Specific conditions that fall under this umbrella include cerebroretinal microangiopathy with calcifications and cysts (Coats plus syndrome), retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S), and other related entities. The body systems primarily affected are the central nervous system and the eyes, though some conditions may also involve other organs such as the liver, bones, or gastrointestinal tract. Treatment for these conditions is largely supportive and symptom-directed, as no curative therapies currently exist for most disorders in this group. Management may include ophthalmological interventions such as laser photocoagulation for retinal disease, neurological monitoring, rehabilitation services, and management of complications such as seizures or cognitive impairment. Genetic counseling is recommended for affected families. Research into targeted therapies is ongoing for some specific conditions within this category.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Genetic central nervous system and retinal vascular disease